11-0720
甲醛 溶液
JIS special grade, 36.0-38.0%, contains methanol as stabilizer
别名:
福尔马林
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
线性分子式:
HCHO
化学文摘社编号:
分子量:
30.03
PubChem Substance ID:
UNSPSC Code:
41115710
Beilstein/REAXYS Number:
1209228
MDL number:
eCl@ss:
39021101
Grade:
JIS special grade
Bp:
97 °C ((37% solution) (lit.))
Vapor pressure:
52 mmHg ( 37 °C)
grade
JIS special grade
vapor density
1.03 (vs air)
vapor pressure
52 mmHg ( 37 °C)
form
liquid
autoignition temp.
572 °F
contains
methanol as stabilizer
availability
available only in Japan
concentration
36.0-38.0%
dilution
(for analytical testing)
bp
97 °C ((37% solution) (lit.))
mp
-15 °C (lit.)
density
1.09 g/mL at 25 °C (lit.)
application(s)
sample preparation
SMILES string
[H]C([H])=O
InChI
1S/CH2O/c1-2/h1H2
InChI key
WSFSSNUMVMOOMR-UHFFFAOYSA-N
Still not finding the right product?
Explore all of our products under 甲醛 溶液
signalword
Danger
Hazard Classifications
Acute Tox. 2 Inhalation - Acute Tox. 3 Dermal - Acute Tox. 3 Oral - Carc. 1B - Eye Dam. 1 - Muta. 2 - Skin Corr. 1B - Skin Sens. 1 - STOT SE 2 - STOT SE 3
target_organs
Eyes,Central nervous system, Respiratory system
存储类别
6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
wgk
WGK 3
flash_point_f
181.4 °F
flash_point_c
83 °C
法规信息
新产品
此项目有
相关内容
James Larkin et al.
The New England journal of medicine, 373(1), 23-34 (2015-06-02)
Nivolumab (a programmed death 1 [PD-1] checkpoint inhibitor) and ipilimumab (a cytotoxic T-lymphocyte-associated antigen 4 [CTLA-4] checkpoint inhibitor) have been shown to have complementary activity in metastatic melanoma. In this randomized, double-blind, phase 3 study, nivolumab alone or nivolumab plus
Cindy S Ma et al.
The Journal of experimental medicine, 205(7), 1551-1557 (2008-07-02)
Hyper-immunoglobulin E syndrome (HIES) is a primary immune deficiency characterized by abnormal and devastating susceptibility to a narrow spectrum of infections, most commonly Staphylococcus aureus and Candida albicans. Recent investigations have identified mutations in STAT3 in the majority of HIES
Arpeeta Sharma et al.
Diabetes, 64(11), 3937-3950 (2015-06-28)
Patients with diabetes have an increased risk of developing atherosclerosis. Endothelial dysfunction, characterized by the lowered bioavailability of endothelial NO synthase (eNOS)-derived NO, is a critical inducer of atherosclerosis. However, the protective aspect of eNOS in diabetes-associated atherosclerosis remains controversial
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 11-0720-5-500ML-J | 04061837741012 |